Steven Simonson - Aug 23, 2023 Form 4 Insider Report for WINDTREE THERAPEUTICS INC /DE/ (WINT)

Role: SVP, Chief Medical Officer
Signature: /s/ Jamie McAndrew, as Attorney-in-Fact
Stock symbol: WINT
Transactions as of: Aug 23, 2023
Transactions value $: $0
Form type: 4
Date filed: 8/25/2023, 06:01 PM
Previous filing: Mar 2, 2023
Next filing: Jul 24, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	WINT	Common Stock	Award	$0	+15.9K	+1008.71%	$0.00	17.4K	Aug 23, 2023	Direct	F1
holding	WINT	Common Stock						6	Aug 23, 2023	By Trust	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	WINT	Employee Stock Option (Right to Buy)	Award	$0	+23.8K		$0.00	23.8K	Aug 23, 2023	Common Stock	23.8K	$1.21	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares represent restricted stock units (RSUs), which represent a contingent right to receive the equivalent number of shares of common stock. These RSUs shall vest with respect to one-third of the total number of shares subject to the RSUs on an annual basis (every 12 months) with the first vest date on August 23, 2024 provided that the reporting person remains in continuous service on each vesting date.
F2	Holding amount represents issuer's matching stock contribution pursuant to 401(k) plan.
F3	This employee stock option shall vest and become exercisable with respect to one-third of the total number of shares subject to the option on an annual basis (every 12 months) with the first vest date on August 23, 2024 provided that the reporting person remains in continuous service on each vesting date.